Loading…
Reported covered position: Legislative Asst, Rep Jim Davis; Sr Legislative Asst, Rep Bart Stupak; Professional Staff, Energy & Commerce Committee; Sr Investigator, US Senate Committee on the Judiciary
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
COMBAT Act of 2018
Client: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA · Firm: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)
340B (no specific bill); COMBAT Act (H.R. 5080); SUPPORT for Patients and Communities Act (H.R.6); Issues related to Medicare generally.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
Issues related to Medicare and opioids; Issues related to BARDA funding; Appropriations
Innovation ACT; Issues related to patents.
Source: Senate LDA
340B (no specific bill); COMBAT Act (H.R. 5080); SUPPORT for Patients and Communities Act (H.R.6); Issues related to Medicare generally.
SUPPORT for Patients and Communities Act
Client: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA · Firm: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)
340B (no specific bill); COMBAT Act (H.R. 5080); SUPPORT for Patients and Communities Act (H.R.6); Issues related to Medicare generally.
SUPPORT for Patients and Communities Act
Client: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA · Firm: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)
340B (no specific bill); COMBAT Act (H.R. 5080); SUPPORT for Patients and Communities Act (H.R.6); Issues related to Medicare generally.
21st Century Cures Act
Client: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA · Firm: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)
21st Century CURES Act (H.R.6); Issues related to "real world" clinical evidence; Issues related to Opioid abuse and alternatives to opioids (no specific bill number); Issues related to Medicare and Medicaid
Innovation Act
Client: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA · Firm: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)
Innovation ACT (H.R.9); Issues related to patents.
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA · Firm: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)
H.R.1 (Tax Cuts and Jobs Act)
American Health Care Act of 2017
Client: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA · Firm: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)
H.R.1628- American Health Care Act of 2017; Issues related to Medicare and opioids.
American Health Care Act of 2017
Client: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA · Firm: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)
H.R.1628- American Health Care Act of 2017; Issues related to Medicare and opioids.
American Health Care Act of 2017
Client: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA · Firm: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)
H.R.1628- American Health Care Act of 2017; Issues related to Medicare and opioids.
21st Century Cures Act
Client: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA · Firm: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)
21st Century CURES Act (H.R.6); Issues related to "real world" clinical evidence; Issues related to Opioid abuse and alternatives to opioids (no specific bill number).
21st Century Cures Act
Client: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA · Firm: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)
Highly enriched to Low enriched uranium (HEU-LEU) related issues for Nuclear Medicine (no specific bill number); 21st Century CURES Act (H.R.6); Issues related to "real world" clinical evidence; Issues related to Opioid abuse and alternatives to opioids (no specific bill number).
21st Century Cures Act
Client: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA · Firm: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)
21st Century CURES Act (H.R.6); Issues related to "real world" clinical evidence; Issues related to Opioid abuse and alternatives to opioids (no specific bill number).
21st Century Cures Act
Client: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA · Firm: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)
21st Century CURES Act (H.R.6); Issues related to "real world" clinical evidence; Issues related to Opioid abuse and alternatives to opioids (no specific bill number).
Innovation Act
Client: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA · Firm: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)
Innovation ACT (H.R.9) Issues related to patents.
Innovation Act
Client: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA · Firm: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)
Innovation ACT (H.R.9); Issues related to patents.
Innovation Act
Client: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA · Firm: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)
Innovation ACT (H.R.9); Issues related to patents.
Innovation Act
Client: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA · Firm: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)
Innovation ACT (H.R.9); Issues related to patents.
21st Century Cures Act
Client: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA · Firm: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)
Highly enriched to Low enriched uranium (HEU-LEU) related issues for Nuclear Medicine (no specific bill number); 21st Century CURES Act (H.R.6); Issues related to "real world" clinical evidence; Issues related to Opioid abuse and alternatives to opioids (no specific bill number).
21st Century Cures Act
Client: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA · Firm: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)
Highly enriched to Low enriched uranium (HEU-LEU) related issues for Nuclear Medicine (no specific bill number); 21st Century CURES Act (H.R.6); Issues related to "real world" clinical evidence; Issues related to Opioid abuse and alternatives to opioids (no specific bill number).
21st Century Cures Act
Client: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA · Firm: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)
Highly enriched to Low enriched uranium (HEU-LEU) related issues for Nuclear Medicine (no specific bill number); 21st Century CURES Act (H.R.6); Issues related to "real world" clinical evidence; Issues related to Opioid abuse and alternatives to opioids (no specific bill number).
21st Century Cures Act
Client: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA · Firm: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)
Highly enriched to Low enriched uranium (HEU-LEU) related issues for Nuclear Medicine (no specific bill number); 21st Century CURES Act (H.R.6)Issues related to "real world" clinical evidence; Issues related to Opioid abuse and alternatives to opioids (no specific bill number).
Innovation Act
Client: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA · Firm: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)
Innovation ACT (H.R.9) Issues related to patents.
Innovation Act
Client: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA · Firm: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)
Innovation ACT (H.R.9) Issues related to patents.
Innovation Act
Client: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA · Firm: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)
Innovation ACT (H.R.9) Issues related to patents.
Innovation Act
Client: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA · Firm: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)
Innovation ACT (H.R.9) Issues related to patents.
21st Century Cures Act
Client: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA · Firm: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)
Highly enriched to Low enriched uranium (HEU-LEU) related issues for Nuclear Medicine (no specific bill number); 21st Century CURES Act (H.R.6)Issues related to "real world" clinical evidence; Issues related to Opioid abuse and alternatives to opioids (no specific bill number)
21st Century Cures Act
Client: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA · Firm: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)
Highly enriched to Low enriched uranium (HEU-LEU) related issues for Nuclear Medicine (no specific bill number); 21st Century CURES Act (H.R.6)Issues related to "real world" clinical evidence; Issues related to Opioid abuse and alternatives to opioids (no specific bill number).
Innovation Act
Client: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA · Firm: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)
Innovation ACT (H.R.9)Issues related to patents.
Innovation Act
Client: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA · Firm: ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)
Innovation ACT (H.R.9)Issues related to patents
340B (no specific bill); COMBAT Act (H.R. 5080); SUPPORT for Patients and Communities Act (H.R.6); Issues related to Medicare generally.
Issues related to "real world" clinical evidence; Issues related to Opioid abuse and alternatives to opioids (no specific bill number); Issues related to Medicare and Medicaid; Issues related to Medicare and Medicaid reimbursement and coverage, DEA modernization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Medicare and opioids; Issues related to BARDA funding; Appropriations
Innovation ACT; Issues related to patents.
340B (no specific bill); COMBAT Act (H.R. 5080); SUPPORT for Patients and Communities Act (H.R.6); Issues related to Medicare generally.
Issues related to "real world" clinical evidence; Issues related to Opioid abuse and alternatives to opioids (no specific bill number); Issues related to Medicare and Medicaid; Issues related to Medicare and Medicaid reimbursement and coverage, DEA Modernization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Medicare and opioids; Issues related to BARDA funding; Appropriations
340B (no specific bill); Issues related to Medicare generally.
21st Century CURES Act (H.R.6); Issues related to "real world" clinical evidence; Issues related to Opioid abuse and alternatives to opioids (no specific bill number); Issues related to Medicare and Medicaid
Innovation ACT (H.R.9); Issues related to patents.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Innovation ACT (H.R.9); Issues related to patents.
H.R.1628- American Health Care Act of 2017; Issues related to Medicare and opioids.
21st Century CURES Act (H.R.6); Issues related to "real world" clinical evidence; Issues related to Opioid abuse and alternatives to opioids (no specific bill number).
H.R.1 (Tax Cuts and Jobs Act)
340B (no specific bill); Issues related to Medicare generally.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
340B (no specific bill); Issues related to Medicare generally.
21st Century CURES Act (H.R.6); Issues related to "real world" clinical evidence; Issues related to Opioid abuse and alternatives to opioids (no specific bill number).
H.R.1628- American Health Care Act of 2017; Issues related to Medicare and opioids.
Innovation ACT (H.R.9); Issues related to patents.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
Issues related to "real world' clinical evidence; Issues related to Opioid abuse and alternatives to opioids; Issues related to patents; Issues related to Medicare and Nuclear Medicine; Drug pedigree and compounding; Regulation of controlled substances.
Issues related to "real world' clinical evidence; Issues related to Opioid abuse and alternatives to opioids; Issues related to patents; Issues related to Medicare and Nuclear Medicine; Drug pedigree and compounding; Regulation of controlled substances.
H.R.1628- American Health Care Act of 2017; Issues related to Medicare and opioids.
340B (no specific bill); Issues related to Medicare generally.
Innovation ACT (H.R.9); Issues related to patents.
Innovation ACT (H.R.9) Issues related to patents.
Highly enriched to Low enriched uranium (HEU-LEU) related issues for Nuclear Medicine (no specific bill number); 21st Century CURES Act (H.R.6); Issues related to "real world" clinical evidence; Issues related to Opioid abuse and alternatives to opioids (no specific bill number).
Issues related to Medicare and opioids.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
Highly enriched to Low enriched uranium (HEU-LEU) related issues for Nuclear Medicine (no specific bill number); 21st Century CURES Act (H.R.6); Issues related to "real world" clinical evidence; Issues related to Opioid abuse and alternatives to opioids (no specific bill number).
Innovation ACT (H.R.9) Issues related to patents.
Issues related to Medicare and opioids.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
Highly enriched to Low enriched uranium (HEU-LEU) related issues for Nuclear Medicine (no specific bill number); 21st Century CURES Act (H.R.6); Issues related to "real world" clinical evidence; Issues related to Opioid abuse and alternatives to opioids (no specific bill number).
Issues related to Medicare and opioids.
Innovation ACT (H.R.9) Issues related to patents.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
Highly enriched to Low enriched uranium (HEU-LEU) related issues for Nuclear Medicine (no specific bill number); 21st Century CURES Act (H.R.6); Issues related to "real world" clinical evidence; Issues related to Opioid abuse and alternatives to opioids (no specific bill number).
Issues related to Medicare and opioids.
Innovation ACT (H.R.9) Issues related to patents.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
Innovation ACT (H.R.9) Issues related to patents.
Issues related to Medicare and opioids.
Highly enriched to Low enriched uranium (HEU-LEU) related issues for Nuclear Medicine (no specific bill number); 21st Century CURES Act (H.R.6)Issues related to "real world" clinical evidence; Issues related to Opioid abuse and alternatives to opioids (no specific bill number).
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
Innovation ACT (H.R.9)Issues related to patents.
Highly enriched to Low enriched uranium (HEU-LEU) related issues for Nuclear Medicine (no specific bill number); 21st Century CURES Act (H.R.6)Issues related to "real world" clinical evidence; Issues related to Opioid abuse and alternatives to opioids (no specific bill number).
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
Innovation ACT (H.R.9)Issues related to patents
Highly enriched to Low enriched uranium (HEU-LEU) related issues for Nuclear Medicine (no specific bill number); 21st Century CURES Act (H.R.6)Issues related to "real world" clinical evidence; Issues related to Opioid abuse and alternatives to opioids (no specific bill number)
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
Issues related to "real world' clinical evidence; Issues related to Opioid abuse and alternatives to opioids; Issues related to patents; Issues related to Medicare and Nuclear Medicine; Drug pedigree and compounding; Regulation of controlled substances.
Issues related to "real world' clinical evidence; Issues related to Opioid abuse and alternatives to opioids; Issues related to patents; Issues related to Medicare and Nuclear Medicine; Drug pedigree and compounding; Regulation of controlled substances.
21st Century CURES Act (H.R.6); Issues related to "real world" clinical evidence; Issues related to Opioid abuse and alternatives to opioids (no specific bill number).
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE